It was reported on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 4.One xtw clip was implanted, reducing mr to a grade of <1.On (b)(6) 2023, the patient returned to the hospital with symptoms of heart failure, supraventricular tachycardia, low ejection fraction, and fluid overload.Echocardiography showed the implanted clip detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachment/slda), causing mr to return to a grade of 3.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the cause of the reported incomplete coaptation could not be determined.The reported mitral regurgitation (mr) appears to be a cascading effect of the reported incomplete coaptation.The reported heart failure (hf), tachycardia and pleural effusion are cascading effects of the reported mr.Additionally, the reported patient effects of mitral regurgitation, heart failure, cardiac arrhythmias, and pericardial effusion are listed in the instructions for use, and are known possible complications associated with mitraclip procedures.The reported hospitalization was a result of case-specific circumstances as the patient was admitted to the hospital to get treated for the reported patient effects.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|